Yu E, Sharma S. Cystic Fibrosis. Treasure Island (FL): StatPearls Publishing; 2018.
Муковисцидоз. Под ред. Н.И. Капранова, Н.Ю. Каширской. М.; Медпрактика, 2014.
Sanders DB, Fink AK. Background and Epidemiology. Pediatr Clin North Am. 2016; 63(4): 567-84.
Masekela R, Vosloo S, Venter SN, de Beer WZ, Green RJ. The lung microbiome in children with HIV-bronchiectasis: a cross-sectional pilot study. BMC Pulm Med. 2018; 18(1): 87. doi: 10.1186/s12890-018-0632-6.
Walicka-Serzysko K, Peckova M, Noordhoek JJ, Sands D, Drevinek P. Insights into the cystic fibrosis care in Eastern Europe: Results of survey. J Cyst Fibros. 2018. pii: S1569-1993(18)30088-2. doi: 10.1016/j.jcf.2018.04.003.
Salsgiver EL, Fink AK, Knapp EA, LiPuma JJ, Olivier KN, Marshall BC et al. Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis. Chest. 2016; 149(2): 390-400.
Schmidt M, Werbrouck A, Verhaeghe N, De Wachter E, Simoens S, Annemans L et al. Strategies for newborn screening for cystic fibrosis: A systematic review of health economic evaluations. J Cyst Fibros. 2018; 17(3): 306-15.
Hwang TC, Yeh JT, Zhang J, Yu YC, Yeh HI, Destefano S. Structural mechanisms of CFTR function and dysfunction. J Gen Physiol. 2018; 150(4): 539-70.
Ren CL, Borowitz DS, Gonska T, Howenstine MS, Levy H, Massie J et al. Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis. J Pediatr. 2017; 181(S):45-51.
Bergougnoux A, Taulan-Cadars M, Claustres M, Raynal C. Current and future molecular approaches in the diagnosis of cystic fibrosis. Expert Rev Respir Med. 2018;12(5):415-426.
Sagel SD, Gibson RL, Emerson J, McNamara S, Burns JL, Wagener JS. et al. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. J Pediatr. 2009; 154(2): 183-8.
Eickmeier O, Boom Lv, Schreiner F, Lentze MJ, NGampolo D, Schubert R. et al. Transforming growth factor β1 genotypes in relation to TGFβ1, interleukin-8, and tumor necrosis factor alpha in induced sputum and blood in cystic fibrosis. Mediators Inflamm. 2013;913135. doi: 10.1155/2013/913135.
Nichols DP, Chmiel JF. Inflammation and its genesis in cystic fibrosis. Pediatr Pulmonol. 2015; 50 (Suppl 40): 39-56.
Cohen-Cymberknoh M, Kerem E, Ferkol T, Elizur A. Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications. Thorax. 2013; 68(12): 1157-62.
Breuer O, Caudri D, Akesson L, Ranganathan S, Stick SM, Schultz A. The clinical significance of oropharyngeal cultures in young children with cystic fibrosis. Eur Respir J. 2018; 51(5). pii: 1800238. doi: 10.1183/13993003.00238-2018.
Hurley MN. Staphylococcus aureus in cystic fibrosis: problem bug or an innocent bystander? Breathe (Sheff). 2018; 14(2): 87-90.
Granchelli AM, Adler FR, Keogh RH, Kartsonaki C, Cox DR, Liou TG. Microbial Interactions in the Cystic Fibrosis Airway. J Clin Microbiol. 2018. pii: JCM.00354-18. doi: 10.1128/JCM.00354-18.
Jaudszus A, Arnold C, Hentschel J, Hünniger K, Baier M, Mainz JG. Increased cytokines in cystic fibrosis patients’ upper airways during a new Ps. aeruginosa colonization. Pediatr Pulmonol. 2018. doi: 10.1002/ppul.24004.
Wojnarowski C, Frischer T, Hofbauer E, Grabner C, Mosgoeller W, Eichler I. et al. Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation. Eur Respir J. 1999; 14(5): 1136-44.
Смирнов И.Е., Кучеренко А.Г., Уртнасан Цэвэгмид, Тыло О.В., Сорокина Т.Е., Волков И.К. Интерлейкины и оксид азота при пороках развития легких и бронхов у детей. Российский педиатрический журнал. 2010; 1: 12-7.
Смирнов И.Е., Кустова О.В., Сорокина Т.Е., Кучеренко А.Г. Маркеры фиброзирования при хронической бронхолегочной патологии у детей. Российский педиатрический журнал. 2015; 18(1): 14-20.
Cosgrove S, Chotirmall SH, Greene CM, McElvaney NG. Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/Toll-like receptor pathway. J Biol Chem. 2011; 286(9): 7692-704.
Heltshe SL, Khan U, Beckett V, Baines A, Emerson J, Sanders DB et al. Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis. J Cyst Fibros. 2017, 27(3): 309-19.
Смирнов И.Е., Тарасова О.В., Лукина О.Ф., Кустова О.В., Сорокина Т.Е., Симонова О.И. Структурно-функциональное состояние легких при муковисцидозе у детей. Российский педиатрический журнал. 2015; 18 (2): 11-7.
De Boeck K, Vermeulen F, Dupont L. The diagnosis of cystic fibrosis. Presse Med. 2017; 46(6 Pt 2): 97-108.
Taylor SL , Rogers GB, Chen AC, Burr LD, McGuckin MA, Serisier DJ. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis Ann Am Thorac Soc. 2015; 12(5): 701-7.
Esther CR Jr, Turkovic L, Rosenow T, Muhlebach MS, Boucher RC, Ranganathan S. et al. Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis. Eur Respir J. 2016; 48(6): 1612-162.
Смирнов И.Е., Соболев С.С., Кучеренко А.Г., Кустова О.В., Симонова О.И., Уртнасан Цэвэгмид. Матриксные металлопротеиназы при хронической бронхолегочной патологии у детей. Российский педиатрический журнал. 2010; 6: 11-4.
Garratt LW, Sutanto EN, Ling KM, Looi K, Iosifidis T, Martinovich KM. et al. Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis. Eur Respir J. 2015; 46(2): 384-94.
Gaggar A, Hector A, Bratcher PE, Mall MA, Griese M, Hartl D. The role of matrix metalloproteinases in cystic fibrosis lung disease. Eur Respir J. 2011; 38(3): 721-7.
McMahan RS, Birkland TP, Smigiel KS, Vandivort TC, Rohani MG, Manicone AM et al. Stromelysin-2 (MMP10) Moderates Inflammation by Controlling Macrophage Activation. J Immunol. 2016; 197(3): 899-909.
Wight TN, Frevert CW, Debley JS, Reeves SR, Parks WC, Ziegler SF. Interplay of extracellular matrix and leukocytes in lung inflammation. Cell Immunol. 2017; 312(1): 1-14.
Corbel M, Belleguic C, Boichot E, Lagente V. Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol Toxicol. 2002; 18(1): 51-61.
Lagente V, Manoury B, Nénan S, Le Quément C, Martin-Chouly C, Boichot E. Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Braz J Med Biol Res. 2005; 38(10): 1521-30.
Chakrabarti S, Patel KD. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res. 2005; 31(6): 599-621.
Roderfeld M, Rath T, Schulz R, Seeger W, Tschuschner A, Graf J. et al. Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation. J Cyst Fibros. 2009; 8(5): 338-47.
Devereux G, Steele S, Jagelman T, Fielding S, Muirhead R, Brady J et al. An observational study of matrix metalloproteinase (MMP)-9 in cystic fibrosis. J Cystic Fibrosis. 2014; 13(5): 57-63.
Harris WT, Muhlebach MS, Oster RA, Knowles MR, Noah TL. Transforming growth factor-beta(1) in bronchoalveolar lavage fluid from children with cystic fibrosis. Pediatr Pulmonol. 2009;44(11):1057-64.
Maloney JP, Narasimhan J, Biller J. Decreased TGF-β1 and VEGF Release in Cystic Fibrosis Platelets: Further Evidence for Platelet Defects in Cystic Fibrosis. Lung. 2016; 194(5): 791-8.
Kramer EL, Clancy JP. TGFβ as a therapeutic target in cystic fibrosis. Expert Opin Ther Targets. 2018; 22(2): 177-89.
Горинова Ю.В., Симонова О.И., Лазарева А.В., Черневич В.П., Смирнов И.Е. Опыт длительного применения ингаляций раствора тобрамицина при хронической синегнойной инфекции у детей с муковисцидозом. Российский педиатрический журнал. 2015; 18(3): 50-3.
Благовидов Д.А., Симонова О.И., Костинов М.П., Смирнов И.Е. Синегнойная инфекция у больных с хроническими неспецифическими заболеваниями легких и проблемы ее вакцинопрофилактики. Российский педиатрический журнал. 2015; 18(6): 54-60.
Ramsey KA, Schultz A, Stick SM. Biomarkers in Paediatric Cystic Fibrosis Lung Disease. Paediatr Respir Rev. 2015; 16(4): 213-8.
Goss CH, Burns JL. Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis. Thorax. 2007; 62(4): 360-7.
Sagel SD, Thompson V, Chmiel JF, Montgomery GS, Nasr SZ, Perkett E Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation. Ann Am Thorac Soc. 2015; 12(5): 708-17.
Rogers GB Inflammation, age and changing microbiology: the search for causation in the cystic fibrosis airways. Eur. Resp. J. 2017 16(1); 50-5.